Recombinant Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine
- Generic Name
- Recombinant Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine
Overview
No overview information available.
Background
No background information available.
Indication
用于预防因高危HPV16/18型所致宫颈癌。本品适用于20-45岁女性。国外已批准本品用于9-19岁女孩接种，但目前中国的临床数据有限。尚未证实本品对已感染疫苗所含HPV型别的人群有预防疾病病的效果。随着年龄増长暴露于HPV的风险升高，因此建议尽早接种本品。
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath